Tenofovir T-shirt

When Antonín Holý filed a patent application in 1984 for a compound later known as tenofovir, he did not anticipate its use against HIV – the virus had been discovered only a year earlier. However, further research revealed its extraordinary potential, and the collaboration between Holý, Belgian virologist Eric De Clercq and their colleagues with John. C. Martin, the director of the U.S. company Gilead Sciences led to the development of drugs that today enable people living with HIV to lead long and healthy lives. Tenofovir also plays an important role in pre-exposure prophylaxis (PrEP), which helps prevent HIV infection, and is instrumental in the treatment of chronic hepatitis B.

Adam is 184 cm tall and wearing size M.